

CLASSIFICATION: NOOTROPIC / NEUROREGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: P21
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 6–8 HOURS
DOSAGE: 250–500 MCG/DAY (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
P21 is a synthetic nootropic peptide originally developed to enhance memory, learning, and neurogenesis in preclinical models of brain injury and cognitive decline. It is based on a modified segment of the CNTF (ciliary neurotrophic factor) and penetratin peptide to facilitate blood-brain barrier transport and receptor binding. Peptide Hubs offers P21 in 5 mg high-purity lyophilized form for research use only.
P21 appears to promote neurogenesis, neurotrophic signaling, and synaptic plasticity by enhancing expression of proteins like GAP-43 and BDNF. It also shows potential to regenerate neuronal architecture in animal models of cognitive injury, particularly in aging or chemically-induced brain damage. This review on peptide nootropics discusses emerging candidates like P21 in neurodegeneration and trauma.
P21 is often paired with N-Acetyl Semax Amidate or N-Acetyl Selank Amidate in emotional memory and neuroplasticity studies. For mitochondrial synergy, researchers combine it with Humanin or MOTS-c. DNA repair models frequently include FOX04-DRI in stacked protocols for cellular senescence and neuroprotection.
P21 is not FDA-approved and is sold strictly for laboratory research. It has shown low toxicity and no hormonal disruption in rodent studies. No known aromatization, liver stress, or cardiovascular effects have been reported. Use in accordance with institutional and regulatory research protocols.
P21 is used in research focused on memory improvement, brain regeneration, neurodegeneration, and cognitive enhancement models.
In animal models, P21 shows a strong safety profile with no hepatotoxicity, blood pressure changes, or hormonal effects.
P21 is commonly stacked with Semax, Selank, Humanin, and FOX04-DRI to explore synergistic effects on cognition and brain aging.
No. P21 is not approved by the FDA or any regulatory body for human or veterinary use. It is intended for laboratory research only.
Please log in to write P21 5 MG review.
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: 2 ML VIAL (30 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–5 HOURS
DOSAGE: 200–500 MCG ONCE OR TWICE DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS